May 15, 2009 / 6:01 AM / 11 years ago

UPDATE 1-Lonza to build cell therapy facility in Singapore

*Says total first phase investment will be 30 mn Sfr

* Says facility will be operational by mid-2011

(Adds detail)

ZURICH, May 15 (Reuters) - Swiss drugs industry supplier Lonza Group LONN.VX said on Friday it was building a new facility in Singapore to expand its cell therapy business.

Lonza said in a press release that the total investment for the first phase would be approximately 30 million Swiss francs ($27.03 million).

Construction is due to begin in early 2010 and the facility is expected to be operational by mid-2011, it added.

“The facility will operate with cutting-edge technologies and a skilled labor force, allowing it to readily meet the needs of a broad range of customers and address the growing global demand for Cell Therapies,” said Lonza CEO Stefan Borgas in a statement. ($1=1.110 Swiss Franc) (Reporting by Martin de Sa’Pinto; editing by Simon Jessop)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below